These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15857742)

  • 1. Measurement of QTc in patients receiving chronic methadone therapy.
    Cruciani RA; Sekine R; Homel P; Lussier D; Yap Y; Suzuki Y; Schweitzer P; Yancovitz SR; Lapin JA; Shaiova L; Sheu RG; Portenoy RK
    J Pain Symptom Manage; 2005 Apr; 29(4):385-91. PubMed ID: 15857742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
    Krantz MJ
    J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QTc prolongation and torsades de pointes associated with methadone therapy.
    Routhier DD; Katz KD; Brooks DE
    J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F; Marti-Almor J; Pastor A; Cladellas M; Farré M; de la Torre R; Torrens M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):327-32. PubMed ID: 18774239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence.
    Chang KC; Huang CL; Liang HY; Chang SS; Wang YC; Liang WM; Lane HY; Chen CH; Stephen Huang SK
    J Cardiovasc Electrophysiol; 2012 May; 23(5):527-33. PubMed ID: 22136144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: A prospective 9-month follow-up study.
    Fredheim OM; Borchgrevink PC; Hegrenaes L; Kaasa S; Dale O; Klepstad P
    J Pain Symptom Manage; 2006 Aug; 32(2):180-5. PubMed ID: 16877186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
    Peles E; Bodner G; Kreek MJ; Rados V; Adelson M
    Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone and torsade de pointes: case report and review of the literature.
    Iskandar SB; Abi-Saleh BS; Mechleb BK; Fahrig SA
    Tenn Med; 2007 Feb; 100(2):35-7, 42. PubMed ID: 17378505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsades de pointes with methadone.
    Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic methadone therapy complicated by torsades de pointes: a case report.
    Pimentel L; Mayo D
    J Emerg Med; 2008 Apr; 34(3):287-90. PubMed ID: 18022786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged QT interval by methadone: relevance for daily practice? A prospective study in patients with cancer and noncancer pain.
    van den Beuken-van Everdingen MH; Geurts JW; Patijn J
    J Opioid Manag; 2013; 9(4):263-7. PubMed ID: 24353019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.
    Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA
    Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
    Roy AK; McCarthy C; Kiernan G; McGorrian C; Keenan E; Mahon NG; Sweeney B
    Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
    Pearson EC; Woosley RL
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
    Perrin-Terrin A; Pathak A; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QTc interval prolongation in patients on long-term methadone maintenance therapy.
    Maremmani I; Pacini M; Cesaroni C; Lovrecic M; Perugi G; Tagliamonte A
    Eur Addict Res; 2005; 11(1):44-9. PubMed ID: 15608471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
    Nair MK; Patel K; Starer PJ
    Addiction; 2008 Dec; 103(12):2062-4. PubMed ID: 19469750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.